: Mycobacterium tuberculosis is readily transmitted from person to person. In the majority of healthy persons acquired immunity, consisting of T cells and macrophages, controls growth but does not eradicate M tuberculosis. Persistent organisms can result in clinical tuberculosis when host immunity fails. The interaction of T cells and macrophages is central to this protective immunity. Macrophages serve as antigen presenting cells for M tuberculosis specific T cell and as effector cell for controlling mycobacterial growth. The macrophage also is the primary target for M tuberculosis infection and site of mycobacterial persistence. Despite activation of CD4+, CD8+ and g/d T cells with potent effector functions against M tuberculosis, the organism survives and persists. Thus the outcome of the interaction between M tuberculosis and acquired immunity is determined by the balance between the host mononuclear phagocyte's ability to process and present M tuberculosis antigens to T cell subsets, and M. tuberculosis' ability to modulate and resist macrophage antigen processing function. The M tuberculosis phagosome becomes the critical macrophage organelle where this dynamic balance is expressed. Proposed studies build on experimental systems and new results obtained during the last cycle of support of AI-27243. The three specific aims are: 1. To determine the role of the M tuberculosis phagosome as site for antigen processing of antigens for MHC class I restricted CD4+ T cells, and to determine the role of cytokines (IFN-g, IL- 10, TGF-B) and mycobacterial constituents such as the 19 kDa lipoprotein to modulate antigen-processing for CD4+ T cells. 2. To determine the mechanism for alternate processing of M tuberculosis for MHC class I restricted CD8+ T cells, to determine if alternate antigen processing is modulated to the same degree and by the same factors as for MHC class II antigen processing and to determine roles of the 44 kDa Rv0341 and 71 kDa Rv3808c proteins as antigens for CD8+ T cells. 3. To determine the role of M tuberculosis phagosomes in Vdelta2+gamma delta T cell activation by phosphoantigens, to determine the sensitivity to inhibition by IL-10, TGF-B and 19 kDa lipoprotein of processing of M tuberculosis by mononuclear phagocytes for gamma/delta T cells; to determine mechanism of gamma/delta T cell mediated M tuberculosis growth inhibition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI027243-14
Application #
6434187
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Sizemore, Christine F
Project Start
1989-02-01
Project End
2007-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
14
Fiscal Year
2002
Total Cost
$306,000
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Shukla, Supriya; Richardson, Edward T; Drage, Michael G et al. (2018) Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes. Infect Immun 86:
Athman, Jaffre J; Sande, Obondo J; Groft, Sarah G et al. (2017) Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation. J Immunol 198:2028-2037
Karim, Ahmad Faisal; Reba, Scott M; Li, Qing et al. (2017) Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function. Eur J Immunol 47:1513-1524
Karim, Ahmad F; Sande, Obondo J; Tomechko, Sara E et al. (2017) Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4+ T Cells by Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan. Proteomics 17:
Li, Qing; Karim, Ahmad F; Ding, Xuedong et al. (2016) Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis. Sci Rep 6:27566
Sande, Obondo J; Karim, Ahmad F; Li, Qing et al. (2016) Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL. J Immunol 196:691-702
Athman, Jaffre J; Wang, Ying; McDonald, David J et al. (2015) Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages. J Immunol 195:1044-53
Richardson, Edward T; Shukla, Supriya; Sweet, David R et al. (2015) Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infect Immun 83:2242-54
Richardson, Edward T; Shukla, Supriya; Nagy, Nancy et al. (2015) ERK Signaling Is Essential for Macrophage Development. PLoS One 10:e0140064
Shukla, Supriya; Richardson, Edward T; Athman, Jaffre J et al. (2014) Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog 10:e1004471

Showing the most recent 10 out of 79 publications